Trial Profile
Maternal and Infant Peripartum Nevirapine, Versus Infant Only Peripartum Nevirapine, or Maternal Lopinavir/Ritonavir in Addition to Standard Zidovudine Prophylaxis for the Prevention of Perinatal HIV in Thailand.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2023
Price :
$35
*
At a glance
- Drugs Nevirapine (Primary) ; Lamivudine; Lamivudine/abacavir; Lopinavir/ritonavir; Nevirapine; Zidovudine
- Indications HIV-1 infections
- Focus Therapeutic Use
- 07 Jul 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 22 Jan 2009 Planned number of patients changed from 1398 to 2097 as reported by ClinicalTrials.gov.
- 22 Jan 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.